Executive Summary
Developing Optimal Formulations
Summary: API-sparing development techniques and identification of the appropriate scalable formulation technology to improve drug solubility and enhance oral bioavailability.
View Now
Webinars
Integrated Approach to Spray Drying for Optimized Oral and Vaccine Formulations
Summary: In this webinar, an academic expert will discuss optimal design space parameters involved in developing spray dried dispersion of poorly soluble drugs for oral and vaccine delivery.
View Now
Video
Valuable Lessons for Pharmaceutical Manufacturing During a Pandemic
Summary: Catalent CEO Johh Chiminski discusses how the pandemic has made us question how the future of pharma manufacturing will be altered post Covid-19.
View Now
Webinars
Is My Molecule Suitable for an Orally Disintegrating Tablet?
Summary: This webinar aims to provide clarity on the types of molecules suitable for an ODT format as well as the regulatory pathways for new and established therapies.
View Now
Webinars
Amorphous and Co-Amorphous Systems for Poorly Soluble Drugs
Summary: This webinar provides an overview of co-amorphous research and its recent findings, particularly, the impact of low molecular weight excipient on developability, stability and solubility.
View Now
Webinars
Importance of Pediatric Biopharmaceutics in Design and Manufacture of Pediatric Dose Forms
Summary: Learn about the current challenges in pediatric drug development programs including predicting oral absorption, and in vitro and in silico methods that can be applied to predict behavior in pediatric populations.
View Now
Webinars
Accelerate Your Program: Streamlined Phase Appropriate Technologies & Expertise
Summary: In this webinar, Catalent experts will explain how the phase appropriate expertise and technologies of the OneXpress® Solution can help streamline development and manufacturing, speed up your program timelines and reduce risks to transform your science into a successful treatment.
View Now
Webinars
What Makes Lipid Excipients So Special?
Summary: In this webinar, we explain why a lipid drug development platform can meet the need for speed to clinic and how the innovative lipid excipients and technologies could solve formulation challenges, optimizing bioavailability for early phase molecules, improve patient compliance and bring products faster to market.
View Now
Presentation
Getting Your Molecule From Preclinical Dev to Phase I
Summary: Three early drug development experts present insights and techniques to help your clients get their molecules from preclinical to Phase 1 studies.
View Now
Executive Summary
A Roadmap for Early Development to Commercial Manufacturing
Summary: Phase-appropriate CMC-related activities can facilitate the transition from early development through commercialization.
View Now